PCSK9 and familial hyperaldosteronism: As expected from previous country comparisons on adult patients with FH, the proportion of children with LDLR, APOB or PCSK9 mutations also varied significantly between the countries, and analysis of the relationship between the identified mutation and patient characteristics will be presented elsewhere.